Uppsala 20th April 2020

Nanexa files two more patent applications

Nanexa strengthens its patent portfolio with two more patent applications. The applications were submitted to the UK Patent Office on April 17, 2020. Within the priority year, it is possible to follow up the British patent applications with international applications (PCT applications), which Nanexa intends to do.

The company’s CEO David Westberg comments

Our development work has resulted in two new inventions that we consider to be patentable. It is gratifying to see that our work results in new inventions, and the two patent applications that now have been filed strengthen Nanexa’s already strong patent portfolio.


For further information:

Nanexa AB (publ)

David Westberg, VD

Phone: +46 709 42 83 03

E mail:


About Nanexa AB (publ)

Nanexa AB is a nanotechnology drug delivery company focusing on the development of PharmaShell®, which is a new and groundbreaking drug delivery system that is expected to have great potential in a number of medical indications. Within the framework of PharmaShell®, Nanexa has partnership agreements with among others, AstraZeneca.